As per the report by Fortune Business Insights, The Epinephrine Market size is projected to reach USD 4.08 Billion by 2030, at a CAGR of 11.3% during the.
Artificial intelligence (AI) is already revolutionizing the conduct of science and the practice of medicine. From basic discovery to gaining insights about some
Were the GLP-1 receptor agonist drug s apparent benefits in STEP-HFpEF due solely to weight loss or additional mechanisms? The trial offers a clue, experts say.
Drugmakers have reported five new drug shortages, including medications for lung cancer, hypertension, and eye infections. At least 15 chemotherapies are in short supply.